Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
t-cell source : Www.prnewswire.com save search
CAR T-Cell Therapy for Non-Hodgkin's Lymphoma Market to Showcase Significant Growth at a CAGR of 15% by 2032 | DelveInsight
Published: 2024-04-15 (Crawled : 22:00) - prnewswire.com
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: -0.17%
H: 1.41%
C: -0.22%
t-cell for therapy growth market
Citius Pharmaceuticals Announces FDA Acceptance of the BLA Resubmission of LYMPHIR™ (Denileukin Diftitox) for the Treatment of Adults with Relapsed or Refractory Cutaneous T-Cell Lymphoma
Published: 2024-03-18 (Crawled : 12:30) - prnewswire.com
CTXR | $0.7199 -6.18% -6.58% 880K
|
Health Technology
|
| O: -2.23%
H: 11.11%
C: 0.03%
fda t-cell resubmission treatment pharmaceuticals
Citius Pharmaceuticals Resubmits the Biologics License Application of LYMPHIR™ (Denileukin Diftitox) for the Treatment of Adults with Relapsed or Refractory Cutaneous T-Cell Lymphoma
Published: 2024-02-14 (Crawled : 13:00) - prnewswire.com
CTXR | $0.7199 -6.18% -6.58% 880K
|
Health Technology
|
| O: 8.82%
H: 5.57%
C: 4.31%
t-cell license treatment pharmaceuticals application
France CAR-T Cell Therapy Market 2018-2028F - Expansion of Indications Beyond Hematological Malignancies
Published: 2024-02-09 (Crawled : 16:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.68%
H: 0.0%
C: 0.0%
MO 4 | $42.92 0.12% 0.0% 12M
|
Consumer Non-Durables
|
| O: -0.35%
H: 0.5%
C: 0.4%
beyond cell expansion car-t therapy market
Global CAR T-Cell Therapy Market Analysis Report 2023: Drug type, Indication, Target Antigen, End-user and Region - Forecast to 2030
Published: 2024-01-24 (Crawled : 17:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.39%
H: 0.82%
C: -0.74%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.22%
H: 0.43%
C: -0.39%
SRNE | $0.015 -8.85% 56K
|
Health Technology
|
| O: -63.33%
H: 263.64%
C: 127.27%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.1%
H: 0.43%
C: -0.04%
AUTL | $4.23 -5.58% -5.91% 2.7M
|
Health Technology
|
| O: -0.91%
H: 11.52%
C: 4.94%
drug report t-cell global therapy market
CAR T-Cell Therapy Market to Register Stunning Growth During the Study Period (2019-2032) | DelveInsight
Published: 2024-01-23 (Crawled : 22:00) - prnewswire.com
ACLX | $52.795 -3.02% -3.12% 300K
|
|
| O: 1.59%
H: 1.14%
C: -1.42%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.61%
H: 1.52%
C: 0.03%
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
|
| O: 1.57%
H: 4.94%
C: 1.54%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: 0.29%
H: 0.15%
C: -1.95%
BEAM | $22.74 -3.11% -3.21% 1.1M
|
Health Technology
|
| O: 1.88%
H: 0.88%
C: -2.79%
t-cell therapy growth study market
GenFleet Therapeutics Announces GFH009 Granted with FDA Fast Track, Orphan Drug Designations for Treating R/R Peripheral T-cell Lymphomas and Acute Myeloid Leukemia
Published: 2024-01-11 (Crawled : 11:00) - prnewswire.com
SLS | $1.54 -5.52% -5.84% 1.3M
|
Health Technology
|
| O: 1.84%
H: 1.25%
C: -4.34%
gfh009 fda drug t-cell granted lymphomas leukemia therapeutics
New Study Reports IceCure's ProSense® Boosts Immune Response Against Cancer: Enhances CD8+ T Cell Response
Published: 2024-01-03 (Crawled : 13:00) - prnewswire.com
ICCM | $1.22 0.82% 94K
|
Manufacturing
|
| O: 3.88%
H: 0.0%
C: 0.0%
prosense cell response study
CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology
Published: 2023-12-05 (Crawled : 12:30) - prnewswire.com
GDTC | $2.15 -2.04% 990
|
|
| O: 0.82%
H: 0.82%
C: -3.27%
cell research technology therapeutics
T-cell Therapy Market Size to Grow USD US$ 76.6 billion from 2023-2033 | Says Transparency Market Research Inc.
Published: 2023-11-06 (Crawled : 15:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.54%
H: 0.73%
C: 0.2%
t-cell research therapy market
Actinium Presents Preclinical Data at SITC Demonstrating Actimab-A's Potential to Restore T Cell Immunity in the Solid Tumor Microenvironment Supporting Immunotherapy Combinations
Published: 2023-11-06 (Crawled : 12:30) - prnewswire.com
ATNM | $7.06 1.44% 0.0% 150K
|
Health Technology
|
| O: 0.63%
H: 4.38%
C: -5.01%
cell tumor preclinical immunotherapy potential
Coeptis Therapeutics Announces Research Demonstrating the Potential of SNAP-CAR T-cells to Reduce Tumor Burden and Growth in HER2 and CD20 Expressing Cancers Will be Presented at SITC 2023
Published: 2023-10-31 (Crawled : 13:00) - prnewswire.com
COEP | $0.3271 -2.36% -2.42% 150K
|
|
| O: -1.12%
H: 0.0%
C: -8.71%
cd20 her2 tumor research therapeutics potential growth
Regen BioPharma, Inc. Receives Second Phase Confirmatory Data on its Duracar CAR-T Cell Therapy Program
Published: 2023-10-25 (Crawled : 13:30) - prnewswire.com
RGBP | $0.7 5.69% 1.5K
|
Manufacturing
|
| O: 4.29%
H: 10.0%
C: 10.0%
cell car-t program therapy
Nektar Presents New Responder Data for Rezpegaldesleukin, a First-in-Class Selective Regulatory T-cell Therapy, in Late-Breaking News Oral Presentation at 2023 EADV Congress
Published: 2023-10-13 (Crawled : 12:30) - prnewswire.com
NKTR | News | $1.39 -2.11% -2.16% 960K
|
Health Technology
|
| O: 3.39%
H: 1.63%
C: -0.37%
t-cell congress presentation
Cell Therapy Market to grow by USD 31.04 billion from 2022 to 2027 | Proven effectiveness of CAR T-cell therapy boosts the market - Technavio
Published: 2023-10-04 (Crawled : 18:00) - prnewswire.com
LSTA | $2.79 5.28% 5.02% 9.6K
|
Manufacturing
|
| O: 3.86%
H: 0.93%
C: -2.33%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: 0.59%
H: 0.29%
C: 0.22%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -1.21%
H: 1.3%
C: 1.16%
BCLI A | $0.5339 1.7% 1.67% 190K
|
Health Technology
|
| O: -0.37%
H: 10.94%
C: -4.38%
t-cell cell therapy market
CAR T-cell Therapy for Multiple Myeloma Market to Observe Stunning Growth by 2032, Evaluates DelveInsight | Key Companies - Cartesian, Arcellx, Novartis, Bristol-Myers Squibb, CARsgen, Poseida, Juno, CRISPR, bluebird bio
Published: 2023-09-25 (Crawled : 21:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
MESO | $6.21 3.5% 3.38% 200K
|
Health Technology
|
| O: -3.28%
H: 5.93%
C: 4.24%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: -0.32%
H: 1.81%
C: 1.23%
companies t-cell therapy growth market
City of Hope researchers develop a CAR T cell therapy for advanced ovarian cancer
Published: 2023-08-10 (Crawled : 15:00) - prnewswire.com
FNCTF | News | $11.16 -20.84% 130
|
Communications
| Email alert
Add to watchlist
hope cancer cell city therapy
CAR T-Cell Therapy Market size to grow at a CAGR of 13.44% from 2022 to 2027; Growing Awareness Regarding CAR T-cell Therapy to boost the market growth- Technavio.
Published: 2023-08-09 (Crawled : 08:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 1.92%
H: 0.0%
C: 0.0%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 1.11%
H: 0.53%
C: 0.53%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.07%
H: 0.73%
C: 0.36%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.14%
H: 0.8%
C: 0.43%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.61%
H: 1.07%
C: -0.5%
AUTL | $4.23 -5.58% -5.91% 2.7M
|
Health Technology
|
| O: -2.02%
H: 3.44%
C: 2.75%
t-cell growing therapy market
Citius Pharmaceuticals, Inc. Receives a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for LYMPHIR™ (Denileukin Diftitox) for the Treatment of Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma
Published: 2023-07-29 (Crawled : 20:20) - prnewswire.com
CTXR | $0.7199 -6.18% -6.58% 880K
|
Health Technology
| Email alert
Add to watchlist
drug t-cell food treatment response
Global CAR-T Cell Therapy Market Report 2023: Rise in Awareness Regarding CAR T-Cell Therapy Drives Growth
Published: 2023-07-06 (Crawled : 19:00) - prnewswire.com
CRBU | $3.86 -3.02% -3.11% 1.1M
|
Health Technology
|
| O: 0.32%
H: 25.69%
C: 21.83%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.7%
H: 0.36%
C: -0.76%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.5%
H: 0.14%
C: -1.45%
report t-cell cell global car-t therapy growth market
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.